Tanvex BioPharma USA, Inc. | WebDisclosure

Basculer en Français

10938	Companies
238839	Keywords
167680	Articles
128375	Press releases

Headlines Articles Press releases Tanvex BioPharma USA, Inc.

Home
Companies
Tanvex BioPharma USA, Inc.

BRIEF

published on 08/19/2024 at 13:05, 2 years ago

Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05

FDA Approval Cancer Treatment Healthcare Innovation Biosimilar Neutropenia
BRIEF

published on 08/19/2024 at 13:05, 2 years ago

Tanvex BioPharma USA, Inc. franchit deux étapes réglementaires aux États-Unis : la FDA approuve Nypozi(TM) et la FDA accepte la demande de licence de produits biologiques biosimilaires pour le TX-05

Traitement Du Cancer Approbation De La FDA Biosimilaire Innovation Dans Le Domaine De La Santé Neutropénie
PRESS RELEASE

published on 08/19/2024 at 13:00, 2 years ago

Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05
Tanvex BioPharma USA, Inc. receives FDA approval for NYPOZI™ biosimilar and FDA BLA acceptance for TX-05, showcasing expertise in biologics development and manufacturing

FDA Approval Biologics Tanvex BioPharma NYPOZI TX-05
PRESS RELEASE

published on 10/16/2023 at 14:00, 2 years 10 months ago

Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars

Accesswire

Published on 09/05/2026 at 04:05, 1 day 4 hours ago

Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 1 day 9 hours ago

FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 1 day 9 hours ago

Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 1 day 10 hours ago

Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 1 day 18 hours ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

View all ACCESSWIRE

EQS Group

Published on 09/06/2026 at 06:00, 2 hours 50 minutes ago

CoolFly to Showcase Personal Flight Portfolio and NA80 Flight-Control Technology at IFA Berlin 2026
Published on 09/06/2026 at 05:15, 3 hours 36 minutes ago

Experience AI Companion in Everyday Life at Hisense IFA 2026
Published on 09/05/2026 at 22:20, 10 hours 31 minutes ago

PITAKA Marks Its Next Chapter in Berlin With "Signals in the Wind," Unveiling New iPhone 18 Accessories
Published on 09/05/2026 at 19:35, 13 hours 16 minutes ago

ToolDance Unveils X1 Smart Desktop CNC Mill at IFA 2026
Published on 09/05/2026 at 14:00, 18 hours 51 minutes ago

Global investment boom could create USD 200 billion commercial insurance opportunity amid rising accumulation risks, finds Swiss Re Institute

Les Echos

Published on 09/04/2026 at 18:57, 1 day 13 hours ago

Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 18:57, 1 day 13 hours ago

Déclaration hebdomadaire d'opérations effectuées du 1er au 4 septembre 2026
Published on 09/04/2026 at 18:15, 1 day 14 hours ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 1 day 14 hours ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 1 day 14 hours ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES AOÛT 2026

View all LES ECHOS COMFI WIRE